LIAISON® Calprotectin
Inflammatory Bowel Disease (IBD) diagnosis & monitoring
Key Facts
About DiaSorin
DiaSorin is an Italian multinational company specializing in the development, manufacturing, and commercialization of in vitro diagnostic (IVD) testing solutions, with a core focus on immunodiagnostics. The company leverages its proprietary chemiluminescence technology through the LIAISON® platform to offer a comprehensive menu of automated assays for infectious diseases, endocrinology, and autoimmune disorders. As a publicly traded entity, DiaSorin has established a strong global presence, driven by strategic acquisitions like Luminex, and is dedicated to advancing personalized medicine through accurate and accessible diagnostic tools. Its mission centers on partnering science and automation to empower laboratories and improve patient outcomes worldwide.
View full company profile